Both in Pharmaceuticals
Aprea Therapeutics vs Enveric Biosciences
Over the past year APRE returned −63.2% and ENVB returned −78.8%; their daily moves had a correlation of 0.03.
APRE −63.2% ENVB −78.8%Growth of $1, one year, split-adjusted
| Metric | APRE | ENVB |
|---|---|---|
| Price | $0.5150 | $1.50 |
| Market cap | $6.5M | $6.7M |
| Today | +4.89% | +3.45% |
| 1 month | −23.8% | −0.7% |
| 6 months | −38.9% | −56.9% |
| Year to date | −39.6% | −58.7% |
| 1 year | −63.2% | −73.7% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 1,250.6× | — |
| Net cash | $41.2M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 96.0% | 48.5% |
| Short % of float | 5.9% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).